Algernon Pharmaceuticals Inc (AGNPF)

[shell3]

Monthly is Out

http://thecse.com/sites/default/files/Breathtec_-_CSE_Form_7_-_Monthly_Progress_Report_for_November_2017_Completed.pdf

I've highlighted the changes to blue

FORM 7
MONTHLY PROGRESS REPORT
Name of Listed Issuer: Breathtec Biomedical Inc. (the “Issuer” or the “Company”).
Trading Symbol: BTH
Number of Outstanding Listed Securities: 54,752,024 Date: December 5, 2017
1. Provide a general overview and discussion of the development of the Issuer’s business and operations over the previous month. Where the Issuer was inactive disclose this fact.
During the month of November 2017, the Company continues to focus on advancing the FAIMS platform technology. The R&D Team has made significant improvements to key components of the prototype device, most notably to the ionization source and FAIMS waveform. The Company also continues to evaluate the potential commercial impact of an assortment of biomarkers tested so far to determine the most effective strategy going forward.
2. Provide a general overview and discussion of the activities of management.
Management is focusing on preparing a plan to focus the Company efforts towards biomarkers corresponding to a single disease or metabolic pathway.
3. Describe and provide details of any new products or services developed or offered. For resource companies, provide details of new drilling, exploration or production programs and acquisitions of any new properties and attach any mineral or strategic plan oil and gas or other reports required under Ontario securities law.
4. Describe and provide details of any products or services that were discontinued. For resource companies, provide details of any drilling, exploration or production programs that have been amended or abandoned.
5. Describe any new business relationships entered into between the Issuer, the Issuer’s affiliates or third parties including contracts to supply products or services, joint venture agreements and licensing agreements etc. State whether the
FORM 7 - MONTHLY PROGRESS REPORT

November 5th Report

FORM 7
MONTHLY PROGRESS REPORT
Name of Listed Issuer: Breathtec Biomedical Inc. (the “Issuer” or the “Company”).
Trading Symbol: BTH
Number of Outstanding Listed Securities: 54,752,024 Date: November 1, 2017
Report on Business
1. Provide a general overview and discussion of the development of the Issuer’s business and operations over the previous month. Where the Issuer was inactive disclose this fact.
During the month of October 2017, the Company continues to focus on advancing the FAIMS platform technology. The R&D Team has made significant improvements to key components of the prototype device, most notably to the ionization source and FAIMS waveform. The Company also continues to evaluate the potential commercial impact of an assortment of biomarkers tested so far to determine the most effective strategy going forward.
2. Provide a general overview and discussion of the activities of management.
Management is focusing on preparing a plan to focus the Company efforts towards biomarkers corresponding to a single disease or metabolic pathway.
3. Describe and provide details of any new products or services developed or offered. For resource companies, provide details of new drilling, exploration or production programs and acquisitions of any new properties and attach any mineral or strategic plan oil and gas or other reports required under Ontario securities law.
None at this time.
4. Describe and provide details of any products or services that were discontinued. For resource companies, provide details of any drilling, exploration or production programs that have been amended or abandoned.
None.
5. Describe any new business relationships entered into between the Issuer, the Issuer’s affiliates or third parties including contracts to supply products or services, joint venture agreements and licensing agreements etc. State whether the
FORM 7 – MONTHLY PROGRESS REPORT

Other changes in the Report is also just dates

smoki be safe in Cali - Praying and Thinking of you